This Pharmaceutical Company is Ready to Grow

Aileron Therapeutics Inc. (NASDAQ: ALRN) is a bio pharmaceutical company that focuses on the development of novel oncology drugs. The company’s recently developed ALRN-6924 treatment is in Phase 2A clinical trials for the treatment of advanced solid tumors. The company is also developing leukemia treatments which are currently in Phase 1B testing. Analysts have been […]

GW Pharmaceuticals Stock Still Looks Good for Its Upside

GW Pharmaceuticals PLC (OTC: GWPRF) is an innovative pharmaceutical developer that focuses on CBD (cannabidiol) therapies. It was the first company to receive FDA approval for a cannabis-based drug, and it’s close to releasing its second CBD treatment. Low earnings and hesitation during the COVID19 pandemic have left this stock lingering at the bottom of […]